Catherine Stehman-Breen

SVP, Chief Medical Officer, Sarepta Therapeutics.

Companies

Tenaya Therapeutics, Inc.Board member Jul 29, 2021 to now¹
Dyne Therapeutics, Inc.Board member Sep 16, 2020 to now²
Generation Bio Co.Board member Jun 11, 2020 to now³
Sarepta TherapeuticsSVP, Chief Medical Officer Apr 5, 2017 to Apr 5, 2017⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Generation Bio Co.0 shares⁵Feb 9, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 9, 2026U 4,752 shares of Generation Bio Co.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTenaya Therapeutics, Inc., Board member
2
SEC EDGARDyne Therapeutics, Inc., Board member
3
SEC EDGARGeneration Bio Co., Board member
4
SEC EDGARSarepta Therapeutics, SVP, Chief Medical Officer
5
SEC EDGARGeneration Bio Co. shares after the filing of Feb 9, 2026